Log In
Print
BCIQ
Print
Print this Print this
 

Openvas Co, olmesartan/hydrochlorothiazide (Benicar HTC)

  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionA fixed dose combination of olmesartan and hydrochlorothiazide
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today